These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 1532053)

  • 1. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis.
    Herman JP; Rouge-Pont F; Le Moal M; Abrous DN
    Neuroscience; 1993 Apr; 53(4):1083-95. PubMed ID: 8099430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immunohistochemical analysis.
    Manier M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1991; 42(2):427-39. PubMed ID: 1896133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
    Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
    Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood.
    Abrous DN; Torres EM; Dunnett SB
    Neuroscience; 1993 Jun; 54(3):657-68. PubMed ID: 8332254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
    Rioux L; Gaudin DP; Gagnon C; Di Paolo T; Bédard PJ
    Neuroscience; 1991; 44(1):75-83. PubMed ID: 1770999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrastriatal transplants of embryonic dopaminergic neurons counteract the increase of striatal enkephalin immunostaining but not serotoninergic sprouting elicited by a neonatal lesion of the nigrostriatal dopaminergic pathway.
    Abrous DN; Manier M; Mennicken F; Feuerstein C; Le Moal M; Herman JP
    Eur J Neurosci; 1993 Feb; 5(2):128-36. PubMed ID: 7903185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neonatal lesion of the meso-telencephalic dopaminergic pathway increases intrastriatal D2 receptor levels and synthesis and this effect is reversed by neonatal dopaminergic rich-graft.
    Mennicken F; Savasta M; Chritin M; Feuerstein C; Le Moal M; Herman JP; Abrous DN
    Brain Res Mol Brain Res; 1995 Feb; 28(2):211-21. PubMed ID: 7723620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons.
    Herman JP; Lupp A; Abrous N; Le Moal M; Hertting G; Jackisch R
    Exp Brain Res; 1988; 73(2):236-48. PubMed ID: 3145893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Exp Neurol; 1991 Mar; 111(3):282-92. PubMed ID: 1825638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors.
    Rioux L; Gagnon C; Gaudin DP; Di Paolo T; Bédard PJ
    Neuroscience; 1993 Sep; 56(1):45-51. PubMed ID: 8232916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.